Publicacións en colaboración con investigadores/as de University of the Witwatersrand (55)

2024

  1. Biological use influences the impact of inflammation on risk of major adverse cardiovascular events in rheumatoid arthritis

    RMD Open, Vol. 10, Núm. 3

2023

  1. Blood Composite Scores in Patients with Systemic Lupus Erythematosus

    Biomedicines, Vol. 11, Núm. 10

  2. Challenges in the diagnosis of polymyalgia rheumatica and related giant cell arteritis

    Expert Review of Clinical Immunology, Vol. 19, Núm. 5, pp. 517-526

  3. Circulating interleukin-6 and cardiovascular disease risk in patients with rheumatoid arthritis with low disease activity due to active therapy

    Clinical and experimental rheumatology, Vol. 41, Núm. 7, pp. 1537-1543

  4. Disease Activity Is More Associated with IL-1 Than with IL-6 in Patients with Rheumatoid Arthritis

    Life, Vol. 13, Núm. 1

  5. Endothelin-1 as a Biomarker of Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Associated with Autoimmune Diseases

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

  6. Full characterization of the three pathways of the complement system in patients with systemic lupus erythematosus

    Frontiers in Immunology, Vol. 14

  7. Relationship between Malondialdehyde Serum Levels and Disease Features in a Full Characterized Series of 284 Patients with Systemic Lupus Erythematosus

    Antioxidants, Vol. 12, Núm. 8

  8. Relationship of Fibroblast Growth Factor 23 Serum Levels with Disease Characteristics in Systemic Lupus Erythematosus Patients

    Biomolecules, Vol. 13, Núm. 8

  9. Serum Levels of Lipoprotein Lipase Are Increased in Patients with Inflammatory Bowel Disease

    International journal of molecular sciences, Vol. 24, Núm. 6

  10. Serum Levels of Transforming Growth Factor Beta 1 in Systemic Lupus Erythematosus Patients

    Biomolecules, Vol. 13, Núm. 1

  11. Transforming growth factor beta 1 is associated with subclinical carotid atherosclerosis in patients with systemic lupus erythematosus

    Arthritis Research and Therapy, Vol. 25, Núm. 1

2022

  1. Epidemiological and genetic features of anti-3‑hydroxy-3-methylglutaryl-CoA reductase necrotizing myopathy: Single-center experience and literature review

    European Journal of Internal Medicine, Vol. 101, pp. 86-92

  2. IgA Vasculitis: Influence of CD40, BLK and BANK1 Gene Polymorphisms

    Journal of Clinical Medicine, Vol. 11, Núm. 19

  3. The role of PET/CT in the evaluation of patients with large-vessel vasculitis: Useful for diagnosis but with potential limitations for follow-up

    Rheumatology (United Kingdom)

  4. Vascular Endothelial Growth Factor and Its Soluble Receptor in Systemic Lupus Erythematosus Patients

    Biomolecules, Vol. 12, Núm. 12

2021

  1. Atypical presentation of immunoglobulin G4-related disease as subglottic stenosis: a case-based review

    Rheumatology International, Vol. 41, Núm. 6, pp. 1161-1167

  2. Author Correction: BAFF, APRIL and BAFFR on the pathogenesis of Immunoglobulin-A vasculitis (Scientific Reports, (2021), 11, 1, (11510), 10.1038/s41598-021-91055-z)

    Scientific Reports

  3. BAFF, APRIL and BAFFR on the pathogenesis of Immunoglobulin-A vasculitis

    Scientific Reports, Vol. 11, Núm. 1

  4. Body mass index and disease activity in chronic inflammatory rheumatic diseases: Results of the cardiovascular in rheumatology (CARMA) project

    Journal of Clinical Medicine, Vol. 10, Núm. 3, pp. 1-10